GU Cancer Clinical Trials

DISCLAIMER: All content found on cua.org is provided for information and education purposes. The medical information and clinical trials information is not intended to substitute for the advice of a physician, nor is it intended to provide legal advice. You should always consult your doctor for specific information on personal health matters, or other relevant professionals to ensure that your own circumstances are considered.

The CUA is not responsible in any manner for direct, indirect, special or consequential damages caused and/or arising from your use of cua.org.

Subspecialty
Renal | ON | Recruiting
HALLMARK
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients (HALLMARK)
Sunita Singh
Start Date: October 24, 2024

NCT #: NCT05938712

SPONSOR: University Health Network, Toronto

INFO: https://clinicaltrials.gov/study/NCT05938712

CONTACT: Vesta Lai: vesta.lai@uhn.ca                

416-340-4800 x 8508

Other Canadian Centres:

1. Toronto General Hospital (Toronto)

Renal | ON | Not yet recruiting
4722
Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
Kristin K Clemens, Louise Moist
Start Date: June 1, 2024

NCT #: NCT06396416

SPONSOR: Western University

INFO: https://clinicaltrials.gov/study/NCT06396416

CONTACT: heather.lapier@sjhc.london.on.ca

Other Canadian Centres:

1. London Health Sciences Centre (London)

Renal | BC | Recruiting
ADVANTage, DAIT CTOT-41
Advancing Transplantation Outcomes in Children (ADVANTage)
David Briscoe, Eileen Chambers
Start Date: May 24, 2024

NCT #: NCT06055608

SPONSOR: National Institute of Allergy and Infectious Diseases (NIAID)

INFO: https://clinicaltrials.gov/study/NCT06055608

CONTACT: Monica Ho (Vancouver): 604-875-2000 x 2485                

Monica.Ho@bcchr.ca

Other Canadian Centres:

1. British Columbia Children's Hospital (Vancouver)

Renal | ON | Not yet recruiting
22-6002
EASE-SOT Pilot Study
Istvan Mucsi
Start Date: May 1, 2024

NCT #: NCT06396702

SPONSOR: University Health Network, Toronto

INFO: https://clinicaltrials.gov/study/NCT06396702

CONTACT: Istvan Mucsi: istvan.mucsi@utoronto.ca                      

416-659-6756

Other Canadian Centres:

1. Toronto General Hospital (Toronto)

Renal | QC | Recruiting
V940-004. & 2023-505177-32
A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004)
Start Date: April 10, 2024

NCT #: NCT06307431

SPONSOR: Merck Sharp & Dohme LLC

INFO: https://clinicaltrials.gov/study/NCT06307431

CONTACT: Trialsites@merck.com

Other Canadian Centres:

1. CHU de Quebec - Universite Laval (Quebec City)

Renal | BC, QC | Recruiting
AT-1501-K102, 2021-003830-36 ( EudraCT Number )
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Start Date: December 11, 2023

NCT #: NCT05027906

SPONSOR: Eledon Pharmaceuticals

INFO: https://clinicaltrials.gov/study/NCT05027906

CONTACT: 949-238-8090                      

clinicaltrials@eledon.com

Other Canadian Centres:

1. Providence Health Care - St. Paul's Hospital (Vancouver).                                          

2. Vancouver General Hospital (Vancouver)                                                                                    

3. McGill University Health Centre (Montreal) 

Renal | NS | Not yet recruiting
QuitWIT
Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation (QuitWIT)
Thomas Skinner
Start Date: October 1, 2023

NCT #: NCT05166460

SPONSOR: Thomas Skinner

INFO: https://clinicaltrials.gov/study/NCT05166460

CONTACT: tomaaskinner@gmail.com

Other Canadian Centres:

1. Queen Elizabeth ll Health Sciences Centre (Halifax)

Bladder | BC, NS, ON, QC | Not yet recruiting
CANUCK-01
A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer
Dr. Paul Toren
Start Date: August 30, 2023

NCT #: NCT06018116

SPONSOR: CHU de Quebec-Universite Laval in Collaboration with Cancer Research Society

INFO: https://classic.clinicaltrials.gov/ct2/show/NCT06018116

CONTACT: Paul.Toren@crchudequebec.ulaval.ca (CHUQ)  

Other Canadian Centres:

BCCA-Vancouver Cancer Centre (Vancouver)

QEII Health Sciences Centre (Halifax)

London Regional Cancer Program (London)

University Health Network (Toronto)

McGill University Health Centre (Montreal)

Renal | ON | Not yet recruiting
INCB 99280-205
Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
Incyte Corporation
Start Date: August 29, 2023

NCT #: NCT05909995

SPONSOR: Incyte Corporation

INFO: https://clinicaltrials.gov/study/NCT05909995

CONTACT: 1-855-463-3464

medinfo@incyte.com

Other Canadian Centres:

Princess Margaret Cancer Centre (Toronto)

Renal | ON | Recruiting
1000080780
iParent2Parent Peer Support Program for Parents of Pediatric Kidney Transplant Recipients
Samantha J. Anthony
Start Date: August 1, 2023

NCT #: NCT05968833

SPONSOR: The Hospital for Sick Children

INFO: https://clinicaltrials.gov/study/NCT05968833

CONTACT: 416-813-7654 ext 303126                     

samantha.anthony@sickkids.ca

Other Canadian Centres:

1. The Hospital for Sick Children (Toronto)

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy